The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC The FDA's Current Position on Peptides Explained Holt Law Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance Sports Medicine Springer Nature Link Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law